109 related articles for article (PubMed ID: 28959839)
1. [Preparation and antitumor effects of tanshinone ⅡA loaded albumin nanoparticles].
Chen C; Wang HJ; Liu FR; Wang Y; Mao SJ; Jin H
Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(4):696-701. PubMed ID: 28959839
[TBL] [Abstract][Full Text] [Related]
2. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology.
Li L; Zhao X; Yang C; Hu H; Qiao M; Chen D
Drug Dev Ind Pharm; 2011 Oct; 37(10):1170-80. PubMed ID: 21449822
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of tanshinone ⅡA loaded nanostructured lipid carrier and its in vitro transdermal permeation characteristics].
Zheng J; Shen CY; Pang JY; Xu FC; Liao WB; Hu CX; Xu PH; Han J; Yuan HL
Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(17):3232-3238. PubMed ID: 28920375
[TBL] [Abstract][Full Text] [Related]
4. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
Zhang WL; Liu JP; Liu XX; Chen ZQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
[TBL] [Abstract][Full Text] [Related]
5. TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
Zhang J; Li Y; Fang X; Zhou D; Wang Y; Chen M
Int J Pharm; 2014 Dec; 476(1-2):185-98. PubMed ID: 25223472
[TBL] [Abstract][Full Text] [Related]
6. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of two preparation methods applied in tanshinone II(A)-loaded PLGA nanoparticles].
Gan LC; Hou SX; Bi YQ; Wang CG; Wang XC; Chen QX
Zhongguo Zhong Yao Za Zhi; 2007 Apr; 32(7):578-81. PubMed ID: 17583194
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of CD123 mono-antibody modified tanshinone ⅡA loaded immunoliposome and its in vitro evaluation].
Wang Y; Liu FR; Xiang HL; Qing H; Chen C; Mao SJ; Li H
Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(11):2085-2091. PubMed ID: 28822152
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
Jiang S; Gong X; Zhao X; Zu Y
Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
[TBL] [Abstract][Full Text] [Related]
10. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
12. Development of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitro.
Chu T; Zhang Q; Li H; Ma WC; Zhang N; Jin H; Mao SJ
Int J Pharm; 2012 Mar; 424(1-2):76-88. PubMed ID: 22226873
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and Characterization of Pharmaceutical Properties of Tanshinone Ⅱ_A Microspheres].
Zhu YF; Jiang F; Wu CH; Zhou X; Shen XC; Tao L
Zhong Yao Cai; 2016 Jan; 39(1):138-42. PubMed ID: 30080016
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z
Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262
[TBL] [Abstract][Full Text] [Related]
16. Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo.
Miao FQ; An YL; Yang R; Tang QS; Zhang JQ
Biomed Mater Eng; 2014; 24(1):599-607. PubMed ID: 24211944
[TBL] [Abstract][Full Text] [Related]
17. In vitro anti-tumor activity of the tanshinone IIA against SKOV3 cells.
Huang J; Lin H; Hong Y
Nat Prod Res; 2016 Aug; 30(16):1844-6. PubMed ID: 26252372
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and quality evaluation of tanshinone IIA microemulsion for parenteral injection].
Lu XX; He L; Deng XL; Xu YJ; Long XY
Zhong Yao Cai; 2014 Nov; 37(11):2070-6. PubMed ID: 26027132
[TBL] [Abstract][Full Text] [Related]
19. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
20. [Anti-tumor effect of tanshinone II A, tetrandrine, honokiol, curcumin, oridonin and paeonol on leukemia cell lines].
Shan QQ; Gong YP; Guo Y; Lin J; Zhou RQ; Yang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):362-6. PubMed ID: 22812238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
